Skip to main content
. 2019 Feb;40(2):283–286. doi: 10.3174/ajnr.A5920

Table 2:

Patient characteristics

Total (n = 136) Good Outcome (n = 29) Poor Outcome (n = 107) P Valuea
Age (mean) (SD) 80.6 (10.1) 79.5 (13.2) 81.0 (9.2) .585
Female (No.) (%) 90 (66.2) 20 (69.0) 70 (65.4) .827
Diabetes (No.) (%) 34 (25.0) 5 (17.2) 29 (27.1) .340
Hypertension (No.) (%) 102 (75.0) 21 (72.4) 81 (75.7) .809
Arrhythmia (No.) (%) 84 (61.8) 19 (65.5) 65 (60.7) .674
Coronary heart disease (No.) (%) 41 (30.1) 8 (27.6) 33 (30.8) .822
Hypercholesterolemia (No.) (%) 41 (30.1) 8 (27.6) 33 (30.8) .822
Premorbid mRS (No.) (%) .719
    3 111 (81.6) 23 (79.3) 88 (82.2)
    4 25 (18.4) 6 (20.7) 19 (17.8)
Baseline NIHSS (median) (IQR) 18 (15–22) 15 (12–19) 19 (15–23) .009
ASPECTS (median) (IQR) 9 (8–10) 10 (9–10) 9 (8–10) .051
Intravenous thrombolysis (No.) (%) 61 (44.9) 13 (44.8) 48 (44.9) 1.000
Onset-to-groin (median) (IQR) 240 (180–344) 232 (182–280) 247 (180–357) .250
Groin-to-TICI (median) (IQR) 75 (41–108) 63 (32–97) 77 (46–117) .142
Occlusion site (No.) (%)
    ICA 31 (22.8) 2 (6.9) 29 (27.1) .024
    M1 78 (57.4) 15 (51.7) 63 (58.9) .530
    M2 30 (22.1) 12 (41.4) 18 (16.8) .010
TICI 2b–3 103 (75.7) 27 (93.1) 76 (71.0) .014

Note:—IQR indicates interquartile range.

a

Comparison between patients with good and poor outcomes.